Aarkstore Enterprise
5th December 2014
Pompe Disease (GAA Deficiency) Therapeutics Pipeline Assessment and Market Forecasts to
2019
Browse Full Report @
http://www.aarkstore.com/pharmaceuticals-healthcare/60352/pompe-disease-gaadeficiency-therapeutics-pipeline-assessment-and-market-forecasts
Published: Feb 2012 | No. Of Pages: 59 Pages
PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Summary
The industry analysis specialist, has released its new report, “Pompe Disease (GAA Deficiency) Therapeutics Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and
analysis on the global Pompe Disease (GAA Deficiency) Therapeutics market. The report identifies the key trends
shaping and driving the global Pompe Disease (GAA Deficiency) Therapeutics market. The report also provides
insights on the prevalent competitive landscape and the emerging players expected to significantly alter the
market positioning of the current market leaders. Most importantly, the report provides valuable insights on the
pipeline products within the global Pompe Disease (GAA Deficiency) Therapeutics sector. This report is built using
data and information sourced from proprietary databases, primary and secondary research and in-house analysis
by GlobalData’s team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Pompe Disease (GAA Deficiency)
Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Pompe Disease (GAA Deficiency)
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
Website : http://www.aarkstore.com/
Aarkstore Enterprise
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and
emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
-...